Regen BioPharma Reports Success of its NR2F6 Small Molecule Screening Program for Treating Autoimmune Diseases Read more
CRF Health Partners Innovative US Biotech with TrialMax eCOA Solution for Phase III Prostate Oncology Study Read more
PolyActiva Commences Its First Phase I Clinical Trial with Potential to Improve Daily Lives of Millions of Glaucoma Patients Read more
Pfizer Terminates Domagrozumab (PF-06252616) Clinical Studies for the Treatment of Duchenne Muscular Dystrophy Read more
SunGen Pharma Establishes Injectable Division and Forms Manufacturing Relationship with GRAM Read more